Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1997-3-10
pubmed:abstractText
Transplanted allogeneic marrow grafts often fail to engraft in a lethally irradiated host. Resistance to hemopoietic allograft is a complexed phenomenon involving multiple components. To study the involvement of a hemopoietic cytokine, which was known to play a role for stem cell function, we established lines of mice that were transgenic for human granulocyte colony-stimulating factor (hG-CSF). Elevated and constitutive expression was found in sera (1,041 +/- 242 pg/ml) of these transgenic mice regardless of their sexes and ages. Strong neutrophilic granulocytosis correlated with the elevated G-CSF activity in transgenic mice but not in littermate controls, establishing a functional expression of this cytokine. In lethally irradiated mice transgenic for G-CSF, infusion of fully allogeneic marrow cells induced donor-derived spleen colony. Growth of hemopoietic allografts appeared to be similar to those of syngeneic marrow cells, which indicates inhibition of resistance for allogeneic marrow grafts. Because of a positive correlation, involvement of natural killer (NK) cells in resistance of transplanted allografts has been suggested. Inocula of NK-sensitive lymphoma cells were, however, vigorously rejected in the G-CSF-transgenic mice. This observation indicates that G-CSF may play a role in engraftment of transplanted allogeneic marrow grafts and may represent a component of mechanisms of hemopoietic resistance. Furthermore, this result may be an indication that alloresistance and NK cells use different mechanisms to resist each target.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0160-564X
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
883-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8853800-Animals, pubmed-meshheading:8853800-Base Sequence, pubmed-meshheading:8853800-Bone Marrow Transplantation, pubmed-meshheading:8853800-Female, pubmed-meshheading:8853800-Gene Expression Regulation, Neoplastic, pubmed-meshheading:8853800-Graft Rejection, pubmed-meshheading:8853800-Graft vs Host Reaction, pubmed-meshheading:8853800-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:8853800-Hematopoiesis, pubmed-meshheading:8853800-Humans, pubmed-meshheading:8853800-Killer Cells, Natural, pubmed-meshheading:8853800-Male, pubmed-meshheading:8853800-Mice, pubmed-meshheading:8853800-Mice, Inbred C57BL, pubmed-meshheading:8853800-Mice, Transgenic, pubmed-meshheading:8853800-Molecular Sequence Data, pubmed-meshheading:8853800-Polymerase Chain Reaction, pubmed-meshheading:8853800-Specific Pathogen-Free Organisms, pubmed-meshheading:8853800-Stem Cells, pubmed-meshheading:8853800-Transplantation, Homologous, pubmed-meshheading:8853800-Tumor Cells, Cultured
pubmed:year
1996
pubmed:articleTitle
Selective inhibition of resistance to hemopoietic allografts but not rejection to a natural killer cell sensitive tumor in transgenic mice for granulocyte colony stimulating factor.
pubmed:affiliation
Department of Pathology, Sapporo Medical University, School of Medicine, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't